RedShiftBio, a MassBio member, is hosting a cutting edge symposium focusing on RNA and protein structure utilizing our Microfluidic Modulation Spectroscopy(MMS) technology. The company has organized a fabulous line-up of scientists to present their research on how they are utilizing MMS to solve their scientific challenges. We will hear from Pfizer, Genentech, USP, CUNY and RedShiftBio. Alongside the insightful presentations, there will be a panel discussion focused on the importance of structural characterization of biomolecules for therapeutic development, control reagent characterization, and deeper mechanistic studies.